Free Trial
OTCMKTS:CPMV

Mosaic ImmunoEngineering (CPMV) Stock Price, News & Analysis

Mosaic ImmunoEngineering logo
$0.27 0.00 (0.00%)
As of 05/30/2025

About Mosaic ImmunoEngineering Stock (OTCMKTS:CPMV)

Key Stats

Today's Range
$0.27
$0.27
50-Day Range
$0.27
$0.84
52-Week Range
$0.10
$1.13
Volume
N/A
Average Volume
1,062 shs
Market Capitalization
$1.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.

Receive CPMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mosaic ImmunoEngineering and its competitors with MarketBeat's FREE daily newsletter.

CPMV Stock News Headlines

Mosaic ImmunoEngineering, Inc. (CPMV)
Mosaic Co.
“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
See More Headlines

CPMV Stock Analysis - Frequently Asked Questions

Mosaic ImmunoEngineering's stock was trading at $0.7012 at the beginning of the year. Since then, CPMV shares have decreased by 61.2% and is now trading at $0.2720.
View the best growth stocks for 2025 here
.

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) released its earnings results on Tuesday, May, 20th. The company reported ($0.03) EPS for the quarter.

Shares of CPMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mosaic ImmunoEngineering investors own include BioNxt Solutions (BNXTF), Defense Metals (DFMTF), C3.ai (AI), Applied Genetic Technologies (AGTC), Agile Therapeutics (AGRX), AgriFORCE Growing Systems (AGRI) and

Company Calendar

Last Earnings
5/20/2025
Today
6/01/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CPMV
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.01 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.81) per share
Price / Book
-0.34

Miscellaneous

Free Float
1,377,000
Market Cap
$1.97 million
Optionable
Not Optionable
Beta
0.11
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:CPMV) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners